Nazione: Malesia
Lingua: inglese
Fonte: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
IRON (III)- HYDROXIDE SUCROSE COMPLEX
BAXTER HEALTHCARE (MALAYSIA) SDN. BHD.
IRON (III)- HYDROXIDE SUCROSE COMPLEX
5ml X 5 Vials; 5ml X 10 Vials
BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED
Not Applicable Leggi il documento completo
SUCROFER DOSE (MG OF IRON) SUCROFER DOSE (ML OF SUCROFER) MAXIMUM DILUTION VOLUME OF STERILE 0.9% M/V NACL SOLUTION MINIMUM INFUSION TIME 400 mg 100 mg 500 mg 200 mg 300 mg 5 ml 15 ml 25 ml 10 ml 20 ml 300 ml 500 ml 400 ml 200 ml 100 ml 15 minutes 30 minutes 1.5 hours 2.5 hours 3.5 hours PHARMACEUTICAL FORM PHARMACOLOGICAL PROPERTIES Water for Injection USP q.s. Iron Sucrose Injection USP (20 mg/ml) Sucrofer The volume of distribution of the central compartment corresponded well to the volume of plasma (approximately 3 litres). Pharmacotherapeutic group: Anti-anaemic preparation, iron, parenteral preparation, ATC code: B03 AC Solution for injection or concentrate for solution for infusion. Mechanism of action Following intravenous administration, the polynuclear iron core from the complex is taken up predominantly by the reticuloendothelial system in the liver, spleen, and bone marrow. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml Contains: NAME OF THE MEDICINAL PRODUCT equivalent to elemental iron 20 mg Ferric Hydroxide in Complex with Sucrose Iron Sucrose Injection USP (20 mg/ml) – Sucrofer, is Dark brown viscous aqueous solution. PHARMACODYNAMIC PROPERTIES Iron sucrose, the active ingredient of Sucrofer, is composed of a polynuclear iron (III)-hydroxide core surrounded by a large number of non-covalently bound sucrose molecules. The complex has a weight average molecular weight (Mw) of approximately 43kDa. The polynuclear iron core has a structure similar to that of the core of the physiological iron storage protein ferritin. The complex is designed to provide, in a controlled manner, utilisable iron for the iron transport and storage proteins in the body (i.e., transferrin and ferritin, respectively). In a second step, the iron is used for the synthesis of Hb, myoglobin and other iron-containing enzymes, or stored primarily in the liver in the form of ferritin. PHARMACOKINETIC PROPERTIES Distribution Biotransformation Upon injection, sucrose largely dissociates and the polynuclear iron core is mainly tak Leggi il documento completo